AstraZeneca (AZN) on Thursday announced an AI-driven drug discovery and licensing deal worth up to $1.5B with ...

AstraZeneca partners with insitro on an AI drug discovery deal worth up to $1.86 billion targeting fatty liver disease and ...

AstraZeneca will use insitro’s AI platform to identify potential drug targets for MASH and cardiomyopathies, drawing on its ...

TDB will provide Rs 86 crore to Peptris Technologies for a Rs 172-crore project to advance four AI-discovered experimental ...

Detailed analyses of ligand choice, linkage vector and linker length enabled the development of bitopic inhibitors of ABL1 and EGFR kinases, including an ABL1 inhibitor with enhanced activity against ...

Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...

Changes in the political climate of the United States are spilling into scientific research. While many past administrations, of both parties, supported and funded science funding and education, the ...

Strategic outsourcing, AI, automation and integrated CRO partnerships boost discovery speed, scalability, cost control and customer retention.Dublin, Oct. (GLOBE NEWSWIRE) -- "Drug Discovery Services ...

Traditionally, developing a new drug takes many years and requires a massive financial investment, often involving significant risk and a high likelihood of failure. AI models trained on extensive ...

Shionogi's Efforts to Shorten Development Time Through AI-Driven Drug Discovery Shionogi is leveraging AI to significantly shorten the "drug discovery period"—the time until clinical trials for new ...

TDB-DST signs agreement with Peptris to accelerate AI-driven drug discovery and development: Our Bureau, Mumbai Tuesday, October 13, 2026, 13:30 Hrs [IST] In a significant step to ...